AFP and hepatocellular carcinoma: Urine-based cfDNA methylation panels and combined blood-based multi-marker models (e.g., HCCtect, MCP technology) have shown incremental sensitivity over AFP alone, particularly for early-stage and AFP-negative HCC, with area under the ROC curve (AUC) values frequently above 0.90 [62,68].